Jens Lamerz

851 total citations
26 papers, 503 citations indexed

About

Jens Lamerz is a scholar working on Molecular Biology, Spectroscopy and Oncology. According to data from OpenAlex, Jens Lamerz has authored 26 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Spectroscopy and 5 papers in Oncology. Recurrent topics in Jens Lamerz's work include Advanced Proteomics Techniques and Applications (9 papers), Machine Learning in Bioinformatics (3 papers) and Mass Spectrometry Techniques and Applications (3 papers). Jens Lamerz is often cited by papers focused on Advanced Proteomics Techniques and Applications (9 papers), Machine Learning in Bioinformatics (3 papers) and Mass Spectrometry Techniques and Applications (3 papers). Jens Lamerz collaborates with scholars based in Switzerland, United States and France. Jens Lamerz's co-authors include Paul Cutler, Arno Friedlein, Axel Ducret, Hartmut Selle, Hanno Langen, Hans‐Dieter Zucht, Angélique Augustin, Manuel Tzouros, Neil Parrott and Aki T. Heikkinen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Biochemistry and Scientific Reports.

In The Last Decade

Jens Lamerz

25 papers receiving 484 citations

Peers

Countries citing papers authored by Jens Lamerz

Since Specialization

Citations

This map shows the geographic impact of Jens Lamerz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Lamerz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Lamerz more than expected).

Fields of papers citing papers by Jens Lamerz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Lamerz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Lamerz. The network helps show where Jens Lamerz may publish in the future.

Co-authorship network of co-authors of Jens Lamerz

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Lamerz. A scholar is included among the top collaborators of Jens Lamerz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Lamerz. Jens Lamerz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a blending design space model to control blend uniformity in a mini-batch direct compression line 2025 ·Powder Technology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jens Lamerz	1
2	Pharmacological Enhancement of Adult Hippocampal Neurogenesis Improves Behavioral Pattern Separation in Young and Aged Male Mice 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Benjamin A. Samuels, Michael Saxe, Juergen Wichmann, Denis J. David, Indira Mendez‐David, Angélique Augustin, Holger Fischer, Sabrina Golling, Jens Lamerz, Doris Roth, Martin Graf, Sannah Zoffmann, Luca Santarelli, Ravi Jagasia, René Hen	0
3	QbD Approach to Process Characterization and Quantitative Criticality Assessment of Process Parameters 2024 ·Organic Process Research & Development ·(unknown), Andreas Schuster, Jens Lamerz, Christian Moessner, (unknown), Pirmin C. Hidber, (unknown), (unknown), (unknown), (unknown), Daniel J. Coleman, Stefan Hildbrand	4
4	Impact of non-ionizable lipids and phase mixing methods on structural properties of lipid nanoparticle formulations 2023 ·International Journal of Pharmaceutics ·Anna Pratsinis, Yuchen Fan, (unknown), Michal Hammel, (unknown), Apoorva Sarode, Philippe Ringler, Ľubomír Kováčik, Matthias E. Lauer, Jens Lamerz, Greg L. Hura, Chun‐Wan Yen, Michael Keller	20
5	An Improved Impact Ratio for Identifying Critical Process Parameters in Pharmaceutical Manufacturing Processes 2022 ·PDA Journal of Pharmaceutical Science and Technology ·Jens Lamerz, (unknown), Andreas Schuster, (unknown), Christian Moessner, (unknown), (unknown), (unknown), Stefan Hildbrand, Daniel J. Coleman	3
6	Symmetric signal transduction and negative allosteric modulation of heterodimeric mGlu1/5 receptors 2020 ·Neuropharmacology ·(unknown), Manuel Tzouros, Jens Lamerz, Angélique Augustin, Thorsten Fritzius, (unknown), Michał Stawarski, Adi Raveh, Catherine Diener, Christophe Fischer, Martin Gassmann, Lothar Lindemann, Bernhard Bettler	18
7	Glypican-2 levels in cerebrospinal fluid predict the status of adult hippocampal neurogenesis 2017 ·Scientific Reports ·Sebastian Lugert, Thomas Kremer, Ravi Jagasia, (unknown), Stefan Aigner, Claudio Giachino, Indira Mendez‐David, Alain M. Gardier, Jean‐Philippe Carralot, Hélène Meistermann, Angélique Augustin, Michael Saxe, Jens Lamerz, Gonzalo Durán-Pacheco, Axel Ducret, Verdon Taylor, Denis J. David, Christian Czech	27
8	Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues 2015 ·Molecular & Cellular Proteomics ·(unknown), Jean‐Christophe Tille, Jens Lamerz, (unknown), Thomas McKee, Miro Venturi, Laura Rubbia‐Brandt, Denis F. Hochstrasser, Paul Cutler, Pierre Lescuyer, Axel Ducret	35
9	Factors Governing the Precision of Subvisible Particle Measurement Methods – A Case Study with a Low-Concentration Therapeutic Protein Product in a Prefilled Syringe 2015 ·Pharmaceutical Research ·(unknown), Jens Lamerz, (unknown), (unknown), Michael Adler, Christof Finkler, Jörg Huwyler, Roland Schmidt, Hanns‐Christian Mahler, Atanas V. Koulov	31
10	Quantitative ADME Proteomics – CYP and UGT Enzymes in the Beagle Dog Liver and Intestine 2014 ·Pharmaceutical Research ·Aki T. Heikkinen, Arno Friedlein, Mariette Matondo, Oliver Hatley, Aleksanteri Petsalo, Risto O. Juvonen, Aleksandra Galetin, Amin Rostami‐Hodjegan, Ruedi Aebersold, Jens Lamerz, Tom Dunkley, Paul Cutler, Neil Parrott	45
11	A Novel Immuno-Competitive Capture Mass Spectrometry Strategy for Protein–Protein Interaction Profiling Reveals That LATS Kinases Regulate HCV Replication Through NS5A Phosphorylation* 2014 ·Molecular & Cellular Proteomics ·Hélène Meistermann, Junjun Gao, Sabrina Golling, Jens Lamerz, Sophie Le Pogam, Manuel Tzouros, (unknown), Lore Gruenbaum, Isabel Nájera, Hanno Langen, Klaus Klumpp, Angélique Augustin	13
12	Quantitative Chemical Proteomics Profiling Differentiates Erlotinib from Gefitinib in EGFR Wild-Type Non–Small Cell Lung Carcinoma Cell Lines 2013 ·Molecular Cancer Therapeutics ·Angélique Augustin, Jens Lamerz, Hélène Meistermann, Sabrina Golling, Stefan Scheiblich, Johannes C. Hermann, Guillemette Duchâteau-Nguyen, Manuel Tzouros, David Ávila, Hanno Langen, Laurent Essioux, Barbara Klughammer	16
13	Multiple Protein Analysis of Formalin-fixed and Paraffin-embedded Tissue Samples with Reverse phase Protein Arrays 2013 ·Molecular & Cellular Proteomics ·(unknown), Jens Lamerz, (unknown), (unknown), (unknown), Berthold Gierke, (unknown), Markus F. Templin, Laurent Essioux, Susanne Arbogast, Miro Venturi, Michael Pawlak, Hanno Langen, Thomas H. Schindler	27
14	Determination of free desmosine in human plasma and its application in two experimental medicine studies 2013 ·Analytical Biochemistry ·Jens Lamerz, Arno Friedlein, (unknown), Paul Cutler, Heinz Döbeli	24
15	Development of a 5-plex SILAC Method Tuned for the Quantitation of Tyrosine Phosphorylation Dynamics 2013 ·Molecular & Cellular Proteomics ·Manuel Tzouros, Sabrina Golling, David Ávila, Jens Lamerz, Marco Berrera, Martin Ebeling, Hanno Langen, Angélique Augustin	24
16	Mass Spectrometry-Based Quantification of CYP Enzymes to Establish In Vitro/In Vivo Scaling Factors for Intestinal and Hepatic Metabolism in Beagle Dog 2012 ·Pharmaceutical Research ·Aki T. Heikkinen, Arno Friedlein, Jens Lamerz, Peter Jakob, Paul Cutler, Stephen Fowler, (unknown), (unknown), Thierry Lavé, Neil Parrott	27
17	Deletion of UDP-glucose pyrophosphorylase reveals a UDP-glucose independent UDP-galactose salvage pathway in Leishmania major 2010 ·Glycobiology ·(unknown), Sebastian Damerow, (unknown), Martin Wiese, Ger van Zandbergen, Jens Lamerz, (unknown), Fong‐Fu Hsu, John Turk, Stephen M. Beverley, Françoise H. Routier	22
18	In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma 2008 ·Biochemical Pharmacology ·Marco Jost, Jens Lamerz, Harald Tammen, Christoph Menzel, Ingrid De Meester, Anne‐Marie Lambeir, Koen Augustyns, Simon Scharpé, (unknown), Horst Rose, Michael Jürgens, Peter Schulz‐Knappe, Petra Budde	24
19	Datamining Methodology for LC-MALDI-MS Based Peptide Profiling 2005 ·Combinatorial Chemistry & High Throughput Screening ·Hans‐Dieter Zucht, Jens Lamerz, (unknown), (unknown), (unknown), Harald Tammen, Reto Crameri, Hartmut Selle	16
20	Correlation‐associated peptide networks of human cerebrospinal fluid 2005 ·PROTEOMICS ·Jens Lamerz, Hartmut Selle, Léonardo Scapozza, Reto Crameri, Peter Schulz‐Knappe, Thomas Möhring, Markus Kellmann, (unknown), Hans‐Dieter Zucht	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact